CSIMarket
 
Protara Therapeutics Inc  (NASDAQ: TARA)
 

Protara Therapeutics Inc's Customers Performance

TARA



 
TARA's Source of Revenues

List of TARA Customers




for the same period Protara Therapeutics Inc

List of TARA Customers





Protara Therapeutics Inc's Comment on Sales, Marketing and Customers





  News about Protara Therapeutics Inc Contracts

Protara Therapeutics Presents Encouraging Phase 1a ADVANCED-1 Trial Data and Unveils Study Design for ADVANCED-2 Trial at SUO Meeting



Protara Therapeutics, a clinical-stage company focused on developing transformative therapies for cancer and rare diseases, has recently announced additional promising data from the Phase 1a dose-escalation component of its ongoing ADVANCED-1 clinical trial. The data relates to TARA-002, the company s investigational cell-based therapy for treating high-grade non-muscle invasive bladder cancer (NMIBC). Moreover, Protara plans to unveil the study design for its ADVANCED-2 trial at the 24th Annual Meeting of the Society of Urologic Oncology (SUO) in Washington, D.C. This development has generated significant excitement within the bio-pharmaceutical industry, indicating potential advancements in the t...












TARA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Protara Therapeutics Inc 232.44 0.00 -53.44 51
SUBTOTAL 0.00 0.00 0.00 -

Sources: Protara Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Protara Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Protara Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.